Latest news
PCI Biotech to present at World Vaccine Congress Europe
Oslo, Norway, October 28, 2019 PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present the company’s vaccine technology, fimaVACC, at the World Vaccine Congress Europe. The presentation is named “fimaVACC – a novel technology for enhancing cellular immune responses with protein and peptide-based vaccines” […]
PCI Biotech is hiring a Chief Medical Officer and a Chief Business Officer
PCI Biotech is looking for a Chief Medical Officer and a Chief Business Officer. Please see the below Job descriptions: Chief Medical Officer Chief Business Officer Please send your application to post@pcibiotech.com within 22 October 2019. Contact person: Per Walday, CEO pw@pcibiotech.com, +47 91793429
Capital increase registered and listing of new shares
Oslo, Norway, 9 September 2019. Reference is made to the previous announcements by PCI Biotech Holding ASA (“PCI Biotech” or the “Company”) in respect of the issuance of 40,000 new shares following exercise of employee share options in the Company. The share capital increase resolved by the Board of Directors following the share option exercise […]